TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bio Pharma Norway AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
102
|
119
|
137 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-17
|
0
|
28 |
| Total assets |
269
|
197
|
350 |
| Current assets |
268
|
190
|
346 |
| Current liabilities |
12
|
10
|
152 |
| Equity capital |
157
|
187
|
198 |
| - share capital |
12
|
13
|
14 |
| Employees (average) | 0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
58.4%
|
94.9%
|
56.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-16.7%
|
0%
|
20.4% |
| Return on assets (ROA) |
-6.3%
|
0%
|
8.0% |
| Current ratio |
2233.3%
|
1900%
|
227.6% |
| Return on equity (ROE) |
-10.8%
|
0%
|
14.1% |
| Change turnover |
-10
|
-11
|
-22 |
| Change turnover % |
-9%
|
-8%
|
-14% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.